Renal Pharmacology Recommendations
To view Article Recommendations, you must have an active subscription.
If your access has expired, you can subscribe at $9.95 per month, the first month of your subscription will be free of charge.
If you think you should be able to access this content, please contact us.
Sign in | Subscribe | Recommend to Library
New to F1000? See this week’s top article below for a free preview of a Recommendation.
SECTION HEADS
-
Department of Pediatrics, Le Bonheur Children's Medical Center, Memphis, TN, USA
-
School of Medicine, University of Maryland, Maryland, USA
-
Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI, USA
-
Department of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA
Section Topics
- » Antihypertensive drugs in renal disease
- » Diuretics/antidiuretics
- » Drugs affecting renal blood flow
- » Drugs for calcium & phosphate metabolism
- » Drugs for inflammation
- » Drugs to prevent acute and/or chronic renal failure
- » Drugs used during dialysis
- » Immunosuppressive drugs in renal disease
- » Nephrotoxicity
- » Regulation by peptides/neurotransmitters
- » Renal drug excretion
- » Treatment of anemia in renal failure
LATEST RECOMMENDATION
Mark Cooper and Karin Jandeleit-Dahm, Baker Medical Research Institute and Alfred Hospital, Australia. F1000 Nephrology
TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]
2 Recommendations, most recent by
Neil Sheerin and David Kavanagh, Newcastle University, UK. F1000 Nephrology
- Changes Clinical Practice
- New Finding
- Novel Drug Target
INDIVIDUAL SUBSCRIPTIONS
Get instant access to Article Recommendations from more than 5,000 expert scientists and clinical researchers, assisted by 5,000 associates, by taking out a monthly subscription. The first month of your subscription will be free of charge.
Start your personal subscription today.
Subscribe for $9.95/monthINSTITUTIONAL SUBSCRIPTIONS
Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.
Recommend to your LibrarianIf you are a librarian or information manager, you may request an extended free trial for your academic or corporate institution.
Request an Institutional Trialyour institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.
